Twist Bioscience Corporation
139.92USD
+4.4500 (+3.28%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on TWST.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | -$0.2▼ | -$0.19 | 0 | 1 |
| Next quarter | -$0.14▼ | -$0.1 | 1 | 0 |
| Current year | -$1.2▼ | -$1.19 | 2 | 0 |
| Next year | -$0.4▲ | -$1 | 1 | 0 |
Beat in 2 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | -$0.28 | -$0.56 | -0.28 (-98.5%) |
| 2026-03-31 | -$0.53 | -$0.6 | -0.07 (-12.6%) |
| 2025-12-31 | -$0.52 | -$0.5 | +0.02 (+3.8%) |
| 2025-09-30 | -$0.5 | -$0.45 | +0.05 (+10.0%) |
103 ratings from 20 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| TD Cowen | Maintained | Buy | $115 $190 | Oct 13, 2026 |
| Canaccord Genuity | Maintained | Buy | $120 $205 | Oct 12, 2026 |
| Jefferies | Initiated | Hold | $150 | Oct 8, 2026 |
| Barclays | Maintained | Overweight | $112 $215 | Oct 7, 2026 |
| Guggenheim | Maintained | Buy | $107 $212 | Oct 1, 2026 |
| Leerink Partners | Maintained | Outperform | $160 $190 | Sep 29, 2026 |
| BWS Financial | Maintained | Sell | $45 | Sep 18, 2026 |
| Leerink Partners | Maintained | Outperform | $120 $160 | Sep 17, 2026 |
| BWS Financial | Initiated | Sell | $45 | Sep 9, 2026 |
| UBS | Initiated | Neutral | $144 | Sep 9, 2026 |
| Piper Sandler | Maintained | Overweight | $85 $115 | Aug 5, 2026 |
| Baird | Maintained | Outperform | $113 $115 | Aug 4, 2026 |
| Canaccord Genuity | Maintained | Buy | $90 $120 | Jul 14, 2026 |
| Evercore ISI Group | Downgraded from Outperform | In-Line | $66 $102 | Jul 6, 2026 |
| Guggenheim | Maintained | Buy | $60 $107 | Jun 29, 2026 |
| Barclays | Maintained | Overweight | $65 $95 | Jun 24, 2026 |
| TD Cowen | Maintained | Buy | $68 $89 | Jun 15, 2026 |
| Canaccord Genuity | Initiated | Buy | $90 | Jun 15, 2026 |
| Piper Sandler | Initiated | Overweight | $85 | Jun 11, 2026 |
| Leerink Partners | Upgraded from Market Perform | Outperform | $70 | May 5, 2026 |
| Barclays | Maintained | Overweight | $55 $65 | May 5, 2026 |
| Guggenheim | Maintained | Buy | $55 $60 | May 5, 2026 |
| Baird | Maintained | Outperform | $50 $65 | May 5, 2026 |
| Barclays | Maintained | Overweight | $50 $55 | Apr 14, 2026 |
| Evercore ISI Group | Maintained | Outperform | $52 $56 | Apr 6, 2026 |
211 filings from 18 insiders · 10 buy / 69 sell over 6m
Officers and directors of TWST, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Laponis AdamOfficer, Chief Financial Officer | Sell | 2.5k | $156.30 | $385k | Oct 9, 2026 |
| Leproust Emily M.Director; Officer, Chief Executive Officer | Sell | 45 | $207.46 | $9k | Oct 5, 2026 |
| Leproust Emily M.Director; Officer, Chief Executive Officer | Sell | 146 | $206.84 | $30k | Oct 5, 2026 |
| Leproust Emily M.Director; Officer, Chief Executive Officer | Sell | 297 | $205.78 | $61k | Oct 5, 2026 |
| Leproust Emily M.Director; Officer, Chief Executive Officer | Sell | 290 | $204.80 | $59k | Oct 5, 2026 |
| Leproust Emily M.Director; Officer, Chief Executive Officer | Sell | 432 | $203.61 | $88k | Oct 5, 2026 |
| Leproust Emily M.Director; Officer, Chief Executive Officer | Sell | 1.0k | $202.32 | $206k | Oct 5, 2026 |
| Leproust Emily M.Director; Officer, Chief Executive Officer | Sell | 481 | $201.26 | $97k | Oct 5, 2026 |
| Leproust Emily M.Director; Officer, Chief Executive Officer | Sell | 1.8k | $200.44 | $369k | Oct 5, 2026 |
| Leproust Emily M.Director; Officer, Chief Executive Officer | Sell | 45.7k | $188.88 | $8.64M | Oct 2, 2026 |
| WERNER ROBERT F.Officer, Chief Accounting Officer | Sell | 1.5k | $188.88 | $280k | Oct 2, 2026 |
| Laponis AdamOfficer, Chief Financial Officer | Sell | 8.1k | $188.88 | $1.52M | Oct 2, 2026 |
| Green PaulaOfficer, SVP of Human Resources | Sell | 10.1k | $188.88 | $1.91M | Oct 2, 2026 |
| Finn Patrick JohnOfficer, President and COO | Sell | 25.7k | $188.88 | $4.86M | Oct 2, 2026 |
| Cho DennisOfficer, See Remarks | Sell | 9.5k | $188.88 | $1.80M | Oct 2, 2026 |
| Leproust Emily M.Director; Officer, Chief Executive Officer | Sell | 655 | $200.00 | $131k | Oct 1, 2026 |
| Leproust Emily M.Director; Officer, Chief Executive Officer | Sell | 83 | $184.60 | $15k | Sep 24, 2026 |
| Leproust Emily M.Director; Officer, Chief Executive Officer | Sell | 501 | $183.76 | $92k | Sep 24, 2026 |
| Leproust Emily M.Director; Officer, Chief Executive Officer | Sell | 16 | $182.50 | $3k | Sep 24, 2026 |
| Leproust Emily M.Director; Officer, Chief Executive Officer | Sell | 21 | $181.45 | $4k | Sep 24, 2026 |
No analyst notes on TWST yet.
Members whose judged calls on TWST have played out most reliably.
No settled calls on TWST yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice
Analyst Ratings
12 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 2 | 7 | 3 | 1 | 0 | Buy2.23 |
| 1 mo ago | 2 | 7 | 3 | 1 | 0 | Buy2.23 |
| 2 mo ago | 2 | 7 | 2 | 0 | 0 | Buy2.00 |
| 3 mo ago | 2 | 7 | 2 | 0 | 0 | Buy2.00 |